المساهمون: Selek, Uğur (ORCID 0000-0001-8087-3140 & YÖK ID 27211), Küçük, A., Topkan, E., Haksöyler, V., Mertsoylu, H., Besen, A.A., Pehlivan, B., School of Medicine

المصدر: Therapeutics and Clinical Risk Management

مصطلحات موضوعية: Health care sciences and services, Concurrent chemoradiotherapy, Pancreas cancer, Platelet-to-albumin ratio, Prognosis, Survival outcomes

وصف الملف: pdf

العلاقة: Publisher version; Koç University Institutional Repository; Kucuk, Ahmet, Erkan Topkan, Ugur Selek, Veysel Haksoyler, Huseyin Mertsoylu, Ali Ayberk Besen, and Berrin Pehlivan. ""Significance of Pre-chemoradiotherapy Platelet-to-albumin Ra: TCRM."" Therapeutics and Clinical Risk Management. (2022).; https://dx.doi.org/10.2147/TCRM.S359553Test; IR03651.pdf; WoS; Scopus; PubMed; NA; http://libdigitalcollections.ku.edu.tr/cdm/ref/collection/IR/id/10509Test

الإتاحة: https://doi.org/10.2147/TCRM.S359553Test
http://libdigitalcollections.ku.edu.tr/cdm/ref/collection/IR/id/10509Test

المصدر: Therapeutics and Clinical Risk Management

مصطلحات الفهرس: Health care sciences and services, Concurrent chemoradiotherapy; Pancreas cancer; Platelet-to-albumin ratio; Prognosis; Survival outcomes, Journal article, text/academic publication

URL: http://libdigitalcollections.ku.edu.tr/cdm/ref/collection/IR/id/10509Test
http://worldcat.org/oclc/1360597550/viewonlineTest
Publisher version
Koç University Institutional Repository